Cited by 213Cannabis and Cannabinoid ResearchSchizophrenia research and treatmentPsychedelics and Drug Studies

The DOI matches its Crossref record; 100 of the 102 references it cites were found in a registry or an index.

Cannabis and psychiatric disorders: it is not only addiction

Leweke, F. Markus, Koethe, Dagmar·2008·Addiction Biology

DOI 10.1111/j.1369-1600.2008.00106.x

Open this paper in CoChat — free account

Abstract

Since the discovery of the endocannabinoid system, a growing body of psychiatric research has emerged focusing on the role of this system in major psychiatric disorders like schizophrenia (SCZ), bipolar disorder (BD), major depression and anxiety disorder. Continuing in the line of earlier epidemiological studies, recent replication studies indicate that frequent cannabis use doubles the risk for psychotic symptoms and SCZ. Further points of clinical research interest are alterations of endocannabinoids and their relation to symptoms as well as postmortem analyses of cannabinoid CB 1 receptor densities in SCZ. A possible neurobiological mechanism for the deleterious influence of cannabis use in SCZ has been suggested, involving the disruption of endogenous cannabinoid signaling and functioning. Even though the number of studies is still limited for affective and anxiety disorders, previous results suggest these diseases to be exciting objectives of cannabinoid‐associated research. Therefore, it became apparent that cannabis use is not only frequent in patients suffering from BD, but that it also induces manic symptoms in this group. In addition, prior antipsychotic treatment decreased the numerical density of CB 1 immunoreactive glial cells in bipolar patients. Although the data on the influence of cannabis use on the development of major depression is controversial, cannabinoid compounds could display a new class of medication, as suggested by the antidepressive effects of the fatty acid amino hydrolase inhibitor URB597 in animal models. With numerous open questions and controversial results, further research is required to specify and extend the findings in this area, which provides a promising target for novel pharmacotherapeutic interventions.

Integrity signals

Registry

Crossref · 10.1111/j.1369-1600.2008.00106.x

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Comorbidity of Mental Disorders With Alcohol and Other Drug Abuse: Results From the Epidemiologic Catchment Area (ECA) Study
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,280
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92620-1 · Cited by 1,166
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Glass, M., Faull, R. L. M., & Dragunow, M. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00428-9 · Cited by 1,052
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024

Show all 102 references

Research works printed but not linked: 4

Beringer K, 1932, Zur klinik des haschischrausches, Nervenarzt, 5, 337
10.1007/s00702-007-0660-5 · DOI
Leweke FM, 2007, Program No 118.3.2007
Moreau de Tours J‐J, 1845, Du Hachisch et de L'aliénation Mentale, Études Psychologiques

Sorted by citations

Items 101–200 of 212

The neurobiology of schizophrenia: new leads and avenues for treatment
Bray, N. J., Leweke, F. M., Kapur, S., & Meyer‐Lindenberg, A. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.09.008 · Cited by 26
Self-citation
Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review
Arenas, L. P., Díaz, I., & Arenas, M. C. (2022) · Brain Sciences · doi:10.3390/brainsci12030388 · Cited by 28
At high risk and want to quit: Marijuana use among adults with depression or serious psychological distress
Shi, Y. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.12.013 · Cited by 25
CANreduce 2.0 Adherence-Focused Guidance for Internet Self-Help Among Cannabis Users: Three-Arm Randomized Controlled Trial
Baumgartner, C., Schaub, M. P., Wenger, A., Malischnig, D., Augsburger, M., Walter, M., Berger, T., Stark, L., Ebert, D. D., Keough, M. T., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/27463 · Cited by 27
Blood, adipose tissue and brain levels of the cannabinoid ligands WIN-55,212 and SR-141716A after their intraperitoneal injection in mice: Compound-specific and area-specific distribution within the brain
Barna, I., Till, I., & Haller, J. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.02.001 · Cited by 25
Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein
van der Doef, T. F., Doorduin, J., van Berckel, B. N. M., & Červenka, S. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0140-0 · Cited by 26
Deciphering the mechanisms of reciprocal regulation or interdependence at the cannabinoid CB1 receptors and cyclooxygenase-2 level: Effects on mood, cognitive implications, and synaptic signaling
Stachowicz, K. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105439 · Cited by 23
Cannabis-induced bipolar disorder with psychotic features: a case report.
Khan, M. A., & Akella, S. (2009) · PubMed Central · Cited by 23
Neurosteroid influence on affective tone
Walton, N. L., Antonoudiou, P., & Maguire, J. L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105327 · Cited by 23
Cannabis: The never-ending, nefarious nepenthe of the 21st century: What should the clinician know?
Greydanus, D. E., Kaplan, G., Baxter, L. E., Patel, D. R., & Feucht, C. L. (2015) · Disease-a-Month · doi:10.1016/j.disamonth.2015.01.004 · Cited by 22
Two-part random effects growth modeling to identify risks associated with alcohol and cannabis initiation, initial average use and changes in drug consumption in a sample of adult, male twins
Gillespie, N. A., Lubke, G. H., Gardner, C. O., Neale, M. C., & Kendler, K. S. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.11.015 · Cited by 22
Abuso de cannabis em pacientes com transtornos psiquiátricos: atualização para uma antiga evidência
Diehl, A., Cordeiro, D. C., & Laranjeira, R. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000500007 · Cited by 19
Neurophysiology of Arthritis Pain
McDougall, J. J., & Linton, P. (2012) · Current Pain and Headache Reports · doi:10.1007/s11916-012-0300-0 · Cited by 20
Emerging targets in treating pain
Chang, D. S., Raghavan, R. S., Christiansen, S., & Cohen, S. P. (2015) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000216 · Cited by 19
Adverse Consequences of Co-Occurring Opioid Use Disorder and Cannabis Use Disorder Compared to Opioid Use Disorder Only
Aquino, J. P. D., Sofuoglu, M., Stefanovics, E. A., & Rosenheck, R. A. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1607363 · Cited by 20
Modulation of endocannabinoid-mediated long-lasting disinhibition of striatal output by cholinergic interneurons
Adermark, L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.039 · Cited by 19
Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function
Sbarski, B., & Akirav, I. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.05.008 · Cited by 17
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample
Pisanu, C., Congiu, D., Costa, M. F., Sestu, M., Chillotti, C., Ardau, R., Deiana, V., Manchia, M., Squassina, A., & Zompo, M. D. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.09.025 · Cited by 16
Effects of regular cannabis and nicotine use on acute stress responses: chronic nicotine, but not cannabis use, is associated with blunted adrenocortical and cardiovascular responses to stress
Al’Absi, M., DeAngelis, B. N., Fiecas, M. J. A., Budney, A. J., & ALLEN, S. S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06087-8 · Cited by 16
Therapeutic potential of minor cannabinoids in psychiatric disorders: A systematic review
Cammà, G., Verdouw, M. P., van der Meer, P. B., Groenink, L., & Batalla, A. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.10.006 · Cited by 16
Cannabidiol for at risk for psychosis youth: A randomized controlled trial
Amminger, G. P., Lin, A. P., Kerr, M., Weller, A., Spark, J., Pugh, C., O’Callaghan, S., Berger, M., Clark, S. R., Scott, J. G., et al. (2021) · Early Intervention in Psychiatry · doi:10.1111/eip.13182 · Cited by 17
Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis
Gómez‐Caballero, A., Elejaga-Jimeno, A., del Caño, G. G., Unceta, N., Guerreiro, A. R., Saumell-Esnaola, M., Sallés, J., Goicolea, M. A., & Barrio, R. J. (2021) · Microchimica Acta · doi:10.1007/s00604-021-05029-z · Cited by 15
Cannabis tourists' perceived constraints to engaging in commercial cannabis tourism overseas: a comparison of first-time and repeat tourists
Wen, J., Kozak, M., & Ying, T. (2022) · Asia Pacific Journal of Marketing and Logistics · doi:10.1108/apjml-06-2021-0411 · Cited by 15
The association between cannabis use and depression: a review of the evidence
Degenhardt, L. J., Hall, W., Lynskey, M. T., Coffey, C., & Patton, G. C. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.011 · Cited by 15
Cannabis and mental health.
Fernández‐Artamendi, S., Hermida, J. R. F., Secades‐Villa, R., & García-Portilla, P. (2011) · Actas Españolas de Psiquiatría · Cited by 15
Neurofunctional changes in adolescent cannabis users with and without bipolar disorder
Bitter, S. M., Adler, C. M., Eliassen, J. C., Weber, W. A., Welge, J. A., Burciaga, J., Shear, P. K., Strakowski, S. M., & DelBello, M. P. (2014) · Addiction · doi:10.1111/add.12668 · Cited by 15
Does cannabis use predict aggressive or violent behavior in psychiatric populations? A systematic review
Sorkhou, M., Johnstone, S., Kivlichan, A. E., Castle, D. J., & George, T. P. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2022.2118060 · Cited by 16
International perspectives on physician knowledge, attitudes, and practices related to medical cannabis
Syed, S. A., Singh, J., Elkholy, H. A., Palavra, I. R., Tomičević, M., Eric, A. P., da Costa, M. P., Gülöksüz, S., & Radhakrishnan, R. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1463871 · Cited by 13
Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use
Fang, F., Quach, B. C., Lawrence, K. G., van Dongen, J., Marks, J. A., Lundgren, S., Lin, M., Odintsova, V. V., Costeira, R., Xu, Z., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02310-w · Cited by 12
Adolescent cannabis consumption and schizophrenia: epidemiological and experimental evidences
Parolaro, D. (2010) · Adicciones · doi:10.20882/adicciones.178 · Cited by 12
Determination of substance overdose in two Iranian centers: Comparison between opioids and non-opioids
Taghaddosinejad, F., Arefi, M., فیاض, ا. ف., & Tanhaeivash, R. (2012) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2012.06.012 · Cited by 12
Prevalence of anxiety and depression among engineering students consuming cannabis
Vaziri-harami, R., Vaziri‐harami, S., & Tarom, M. (2022) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2022.104144 · Cited by 11
Cannabis use and resting state functional connectivity in adolescent bipolar disorder
Sultan, A. A., Hird, M. A., Dimick, M. K., MacIntosh, B. J., & Goldstein, B. I. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200228 · Cited by 10
Different pharmaceutical preparations of Δ9‐tetrahydrocannabinol differentially affect its behavioral effects in rats
Rohleder, C., Pahlisch, F., Graf, R., Endepols, H., & Leweke, F. M. (2019) · Addiction Biology · doi:10.1111/adb.12745 · Cited by 10
Self-citation
Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons
Lueneberg, K., Domínguez-Gómez, G., Arias-Carrión, Ó., Palomero‐Rivero, M., Millán‐Aldaco, D., Morán, J., Drucker-Colı́n, R., & Murillo‐Rodríguez, E. (2011) · International Archives of Medicine · doi:10.1186/1755-7682-4-28 · Cited by 9
Cannabidiol zur Verbesserung der Genesung in frühen Stadien einer Schizophrenie
Rohleder, C., Müller, J. K., Hirjak, D., Meyer‐Lindenberg, A., & Leweke, F. M. (2018) · Nervenheilkunde · doi:10.1055/s-0038-1651941 · Cited by 9
Self-citation
Cannabis e humor
Sanches, R. F., & Marques, J. M. D. A. (2010) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462010000200014 · Cited by 10
Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration
Impey, D., El-Marj, N., Parks, A., Choueiry, J., Fisher, D. J., & Knott, V. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.002 · Cited by 9
Current Status and Future of Cannabis Research
Russo, E. B., Mead, A., & Sulak, D. (2015) · doi:10.14524/cr-15-0004 · Cited by 8
Traditional and Modern Health Uses of Cannabis sativa L. in Africa and Its Phytochemical and Pharmacological Profile
Kakudidi, E. K., Tugume, P., Asiimwe, S., & Anywar, G. (2022) · Springer eBooks · doi:10.1007/978-981-16-8822-5_10 · Cited by 7
The Prevalence of Cannabis Use Disorder Comorbidity in Individuals with Bipolar Disorder: A Systematic Review and Meta-Analysis
Bahji, A., Danilewitz, M., Vazquez, G., & Patten, S. (2021) · Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000123 · Cited by 6
The Green Sheep: Exploring the Perceived Risks and Benefits of Cannabis Among Young Military Members and Veterans
Clary, K. L., Habbal, M., Smith, D. C., & Fratila, I. (2021) · Cannabis · doi:10.26828/cannabis/2021.02.003 · Cited by 8
Critical Age Windows for Neurodevelopmental Psychiatric Disorders: Evidence from Animal Models
Marco, E. M., Macrì, S., & Laviola, G. (2010) · Springer eBooks · doi:10.1007/978-1-4614-0785-0_26 · Cited by 7
The prevalence and influencing factors of psychotic-like experiences in children and adolescents: a meta-analysis and systematic review
Tang, S., Xie, Y., Wang, X., You, S., Fu, Y., & Wu, D. (2025) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-025-02905-4 · Cited by 5
Chronic cannabis use in people with bipolar disorder is associated with comparable decision-making and functional outcome to healthy participants
Miranda, A. H., Roberts, B. Z., Holloway, B. M., Peek, E. M., Rosberg, H., Ayoub, S. M., Piomelli, D., Jung, K., Barnes, S. A., Rossi, S. S., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03718-4 · Cited by 5
Tıbbi Esrar Psikiyatrik Bozuklukların Tedavisinde Kullanılabilir mi?
Tellioğlu, T., & Tellioğlu, Z. (2012) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20120223123828 · Cited by 5
The Endocannabinoid System and Human Brain Functions
Ashton, J. C., Dowie, M. J., & Glass, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809666-6.00005-8 · Cited by 7
Cannabis use: A co-existing condition in first-episode bipolar mania patients
Etyemez, S., Currie, T. T., Hamilton, J. E., Weaver, M. F., Findley, J. C., Soares, J. C., & Selek, S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.097 · Cited by 5
The role of aberrant salience in the association between cannabis use frequency and psychotic experiences among racial and ethnic minoritized youth.
Anglin, D. M., Tikhonov, A. A., Tayler, R., & Devylder, J. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.09.016 · Cited by 5
Cannabis, cannabinoids and bipolar disorder
Castle, D. J., & Koethe, D. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.012 · Cited by 5
Self-citation
Bruk av benzodiazepiner og cannabis blant unge voksne
Kornør, H., Pedersen, W., von Soest, T., Rossow, I. M., & Bramness, J. G. (2010) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.09.0188 · Cited by 5
Cannabis and the Mesolimbic System
Cannizzaro, C., & Diana, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00074-2 · Cited by 4
Schizophrenia and Comorbid Substance Abuse – Pathophysiological and Therapeutic Approaches
Wobrock, T., Czesnik, D., & Malchow, B. (2011) · Springer eBooks · doi:10.1007/978-94-007-0834-1_15 · Cited by 4
Marijuana-induced mania in a healthy adolescent: a case report
Iskandar, J. W., Griffeth, B. T., & Sharma, T. R. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.04.007 · Cited by 4
Evaluation of Some Haematological Parameters Among Marijuana Smokers In Yenagoa, Nigeria.
Eledo, B. O., Dioka, C. E., Amilo, G., Ifeanyichukwu, M., & Onuoha, E. C. (2015) · Journals & Books Hosting (International Knowledge Sharing Platform) · Cited by 3
Can Adult Neurogenesis Be Considered as Neuroplasticity?
Famitafreshi, H., & Karimian, M. (2019) · Archives of Neuroscience · doi:10.5812/ans.79812 · Cited by 3
Multimodal Correlates of Cannabis Use among U.S. Veterans with Bipolar Disorder: An Integrated Study of Clinical, Cognitive, and Functional Outcomes
Selloni, A., Bhatia, G., Ranganathan, M., & Aquino, J. P. D. (2022) · Journal of Dual Diagnosis · doi:10.1080/15504263.2022.2053264 · Cited by 3
Mood Disorders in Dual Disorder Heroin Use Disorder Patients
Maremmani, I., Pacini, M., & Maremmani, A. G. I. (2023) · Springer eBooks · doi:10.1007/978-3-031-30093-6_2 · Cited by 3
Tuning the properties of peptide imprinted nanoparticles for protein immunoprecipitation using magnetic streptavidin beads
Elejaga-Jimeno, A., Gómez‐Caballero, A., del Caño, G. G., Unceta, N., Saumell-Esnaola, M., Sallés, J., Goicolea, M. A., & Barrio, R. J. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06782-7 · Cited by 3
Cannabis. Beneficio y riesgo
Maldonado, R. J. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2008.11.009 · Cited by 3
Cannabis
Jager, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_11 · Cited by 3
Comparison between Cannabidiol and Fluoxetine effects on chronic neuropathic pain and depression comorbid in rats
Brito, D. T. P., Medeiros, A. C., Leite‐Panissi, C. R. A., Cárnio, E. C., Machado, H. R., Coimbra, N. C., de Freitas, R. L., & de Medeiros, P. S. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01751-w · Cited by 2
Causas orgánicas y comórbidas de la depresión: el primer paso
Campagne, D. M. (2012) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2011.12.010 · Cited by 2
The role of cannabinoids in the management of symptoms in palliative care patients
Graczyk, M., & Leppert, W. (2021) · Palliative Medicine in Practice · doi:10.5603/pmpi.2021.0016 · Cited by 3
Manejo del consumo de cannabis en población joven en Atención Primaria
Madoz‐Gúrpide, A., & Mangado, E. O. (2011) · Atención Primaria · doi:10.1016/j.aprim.2010.10.002 · Cited by 2
Cannabinoids and schizophrenia
Rohleder, C., & Leweke, F. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417041-4.00008-4 · Cited by 2
Self-citation
Cannabiskonsum zum Freizeitgebrauch
Schneider, M., Friemel, C. M., von Keller, R., Adorjan, K., Bonnet, U., Hasan, A., Hermann, D., Kambeitz, J., Koethe, D., Kraus, L., et al. (2018) · Springer eBooks · doi:10.1007/978-3-662-57291-7_3 · Cited by 2
Self-citation
Wirksamkeit, Verträglichkeit und Sicherheit von medizinischem Cannabis
Hoch, E., Schneider, M., von Keller, R., Bonnet, U., Falkai, P., Hasan, A., Häuser, W., Hinz, B., Jakob, L., Kabisch, J., et al. (2018) · Springer eBooks · doi:10.1007/978-3-662-57291-7_4 · Cited by 2
Large-scale genomic data-mining implicates dysregulated nuclear receptor-mediated signaling in mental illness
Donskov, J. G. (2021) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2021.12 · Cited by 2
Cannabinoids
Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3471-8.00018-4 · Cited by 2
The prevalence of psychiatric illness among cannabis users
Patel, R. S., Shukla, R., Solanki, N., & Chittora, G. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns5.11390 · Cited by 1
Role of the Endocannabinoid System in Anxiety and Stress-Related Disorders
Akirav, I. (2011) · InTech eBooks · doi:10.5772/18405 · Cited by 2
The Cannabinoid System in Nicotine Dependence and Withdrawal
McIlwain, M., Minassian, A., & Perry, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802574-1.00009-0 · Cited by 1
The Ecology of Wild Cannabis sativa
Small, E. (2016) · CRC Press eBooks · doi:10.1201/9781315367583-12 · Cited by 1
Recherche d’association entre abus de cannabis et bipolarité : étude sur un échantillon de patients hospitalisés pour un trouble bipolaire
Kazour, F., Awaida, C. J., Souaiby, L., & Richa, S. (2016) · L Encéphale · doi:10.1016/j.encep.2016.08.005 · Cited by 1
Cannabis induced psychosis - an overview
Chandran, R., Verma, M. M., & Associate Professor in Nursing, A. (2017) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2017.i10.01 · Cited by 1
Cannabis Chemistry: Cannabinoids in Cannabis, Humans, and Other Species
Small, E. (2016) · CRC Press eBooks · doi:10.1201/9781315367583-20 · Cited by 1
Critical Age Windows for Neurodevelopmental Psychiatric Disorders: Evidence from Animal Models
Marco, E. M., Macrì, S., & Laviola, G. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7264-3_31 · Cited by 1
Uso medicinal do canabidiol no tratamento da epilepsia refratária em pacientes pediátricos: um estudo bibliográfico / The medicinal use of cannabidiol in the treatment of refrectory epilepsy in pediatric patients: a biography study
de Araujo, J. I., Soares, R. M., de Andrade, F. G. S., Ribeiro, S. Z. R. D. S., de Araújo, M. F., de Araújo, V. T., Clemente, M. H. S., & Oliveira, J. J. F. S. (2022) · Brazilian Journal of Health Review · doi:10.34119/bjhrv5n3-193 · Cited by 1
The Role of Sex and Coping Styles on the Relationship Between Depression and Cannabis Use
Villanueva‐Blasco, V. J., Mateu-Mollá, J., Vázquez‐Martínez, A., Boubeta, A. R., de Fonseca, F. R., & Folgar, M. I. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01275-3 · Cited by 2
Cannabis et schizophrénie : des liens reconnus
Lévy-Chavagnat, D. (2010) · Actualités Pharmaceutiques · doi:10.1016/s0515-3700(10)70749-7 · Cited by 1
Adicción a cannabis: bases neurobiológicas y consecuencias médicas
Araos, P. F., Calado, M., Vergara‐Moragues, E., Pedraz, M., Pavón, F. J., & de Fonseca, F. R. (2014) · Repository of Digital Objects for Teaching Research and Culture (University of Valencia) · Cited by 1
The Correlation between Schizophrenia Onset and Drugs Consumption
Costache, O. I., Cioara, F., & Suciu, N. R. (2016) · Acta Medica Transilvanica · Cited by 1
Cannabis abuse and self-mutilation
Yassa, A. H., & Sm, G. (2016) · JOURNAL OF FORENSIC SCIENCE & CRIMINOLOGY · doi:10.15744/2348-9804.4.505 · Cited by 1
Comportamentos de saúde em usuários de substâncias psicoativas
Júnior, E. B. C. (2013) · doi:10.11606/d.22.2013.tde-12062013-155132 · Cited by 1
Endocannabinoid involvement in reward and impulsivity in addiction
van Hell, H. H. (2011) · Utrecht University Repository (Utrecht University)
Epidemiological and biological mechanisms of cannabis as cause of psychosis
Kuepper, R. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120504rk
Influence de la consommation de substances sur l'émergence et l'évolution des troubles psychotiques
Dervaux, A. (2010) · HAL
THEMED ISSUE: CANNABINOIDS REVIEW Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
Malone, D. T., Hill, M. N., & Rubino, T. (2010)
A General Survey of its Harmful Effects Submission to The Social Justice Policy Group
Brett, M. (2012)
Consumo de cánnabis de los adolescentes y esquizofrenia: evidencias epidemiológicas y experimentales Adolescent cannabis consumption and schizophrenia: epidemiological and experimental evidences
Parolaro, D. (2010)
Cannabis and Bipolar Manic Episodes
Aubry, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00078-x
Konsekwencje używania i nadużywania marihuany w świetle współczesnej wiedzy The consequences of marijuana use and abuse - a review
Miturska, E., & Moskalewicz, J. (2012)
Amotivational Syndrome Caused by Cannabis Use: A Case Who Improved with Additional Testosterone Combination Treatment
Ekinci, S., & Kural, H. U. (2016) · Journal of Clinical Psychiatry · doi:10.5505/kpd.2016.88597
Biologist and Former Head of Health Education
Brett, M. (2016)
Efeitos comportamentais do canabidiol em um modelo de psicose induzida por S(+)-ketamina em ratos Wistar
Ross, J. B. D. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-12012017-145100
ROLE OF CANNABIS IN PSYCHIATRIC ILLNESSES: A MINI-LITERATURE REVIEW.
WajihUllah, M., Ashraf, F., SamartaAliasMonika, F., Siddiq, W., Fatiwala, Z., Zaheer, S., & Dp., N. (2018) · International Journal of Advanced Research · doi:10.21474/ijar01/7628
P.4.03 The acute effects of cannabidiol on reward processing in humans: an fMRI study
Yim, J. L., Hindocha, C., Yamamori, Y., Jones, A., Walker, H. R., Lawn, W., Lewis, G., Howes, O. D., Curran, H. V., Freeman, T. P., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.01.093
Cannabis and the Impact on the Pediatric and Adolescent Population
Wang, G. S., Greydanus, D. E., & Cabral, M. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-45968-0_5
Trabalho noturno e o risco cardiovascular na equipe de enfermagem
Assunção, M. R. S., Costa, A. C. B., Costa, I. C. P., & Fava, S. M. C. L. (2020) · Revista Recien · doi:10.24276/rrecien2020.10.32.229-238

Authors: Leweke, F. M., & Koethe, D.
Affiliations: University of Cologne (DE)
Corresponding author: Leweke, F. Markus
ORCID: Leweke, F. Markus
Koethe, Dagmar
Venue: Addiction Biology
Publisher: Wiley
Published: 2008-06
Volume: 13
Issue: 2
Pages: 264-275
ISSN: 1355-6215 (ISSN-L)
1369-1600
DOI: 10.1111/j.1369-1600.2008.00106.x
OpenAlex: W2113864940
Cited by: 213
References: 102
Citations by year: 2026: 1 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 12 · 2021: 13 · 2020: 7 · 2019: 11 · 2018: 8 · 2017: 13 · 2016: 20 · 2015: 14 · 2014: 13 · 2013: 9 · 2012: 18
FWCI: 2.15
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 27 d)
Locations: Addiction Biology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords: cannabis use, endocannabinoid system, schizophrenia, bipolar disorder, major depressive disorder, anxiety disorders, psychotic symptoms, CB1 receptor, endocannabinoids, manic symptoms, glial cells, URB597
MeSH terms: Affect, Animals, Anxiety Disorders, Bipolar Disorder, Brain, Cannabinoids, Marijuana Abuse, Cognition Disorders, Depressive Disorder, Major, Major Depressive Disorder, Drug Interactions, Humans, Psychoses, Substance-Induced, Risk Factors, Schizophrenia, Dronabinol, Antipsychotic Agents, Signal Transduction, Mood Disorders, Receptor, Cannabinoid, CB1, Cannabinoid Receptor Modulators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabis and psychiatric disorders: it is not only addiction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks